SEC Files Settled Charges Against Ex-CEO for Misappropriating Corporate Assets
April 30, 2026
April 30, 2026
WASHINGTON, April 30 -- The Securities and Exchange Commission issued the following litigation release (No. 2:26-cv-04554; C.D. Cal. filed April 29, 2026) involving an ex-CEO for misappropriating corporate assets:
* * *
On April 29, 2026, the Securities and Exchange Commission filed a settled action against Anthony J. Cataldo, former Chairman and CEO of a clinical-stage biopharmaceutical company (the Company), for allegedly misappropriating approximately $3.2 million fr . . .
* * *
On April 29, 2026, the Securities and Exchange Commission filed a settled action against Anthony J. Cataldo, former Chairman and CEO of a clinical-stage biopharmaceutical company (the Company), for allegedly misappropriating approximately $3.2 million fr . . .